Treatment of Diffuse Large B-Cell Lymphoma at the Moscow City Clinical Hospital No. 52: A Retrospective Clinical Trial Based on the Single-Center Experience and Analysis of Data from Its In-House Registry

Background. The term diffuse large B-cell lymphoma (DLBCL) defines a heterogeneous group of lymphatic tumors. DLBCL is the most frequent immunomorphological variant among aggressive non-Hodgkin lymphomas (NHLs) in adults. It accounts for 30–40 % of all NHLs. Long-term results of treating newly diagn...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marat Albertovich Mingalimov, E. A. Baryakh, Yu. Yu. Polyakov, E. N. Misyurina, E. I. Zhelnova, K. V. Yatskov, A. B. Makeshova, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, O. L. Kochneva, I. V. Samsonova, M. A. Lysenko
Formato:	Artigo
Idioma:	Russo
Publicado em:	Practical Medicine Publishing House 2024-05-01
coleção:	Клиническая онкогематология
Assuntos:	diffuse large b-cell lymphoma real-world clinical practice healthcare management progression-free survival immunochemotherapy
Acesso em linha:	https://bloodjournal.ru/index.php/coh/article/view/60
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!